Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site’s interface revision was updated from v3.5.0 to v3.5.2 without changing the clinical study details shown on the page.
    Difference
    0.0%
    Check dated 2026-04-21T01:22:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now includes updated definitions and timeframes for primary/secondary outcomes (PFS, OS, ORR), added PK data details, and an additional Naples, Italy site.
    Difference
    1.0%
    Check dated 2026-03-23T06:31:50.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T00:26:56.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page shows a minor version update from Revision: v3.4.1 to Revision: v3.4.2; no study data or visible content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:02:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T09:43:58.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page now includes a glossary display option and a new QC metadata label 'Last Update Submitted that Met QC Criteria' along with a 'No FEAR Act Data' notice. The revision footer shows 'Revision: v3.4.0', replacing the previous 'v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-25T00:51:14.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.